Oncology Biosimilars Market Global Report 2020-30
April 2020
200
About the Report
About the Report
Products
Products
1) By Drug Type: Monoclonal Antibody; Immunomodulators; Hematopoietic Agents; Granulocyte Colony-Stimulating Factor (G-CSF); 2) By Cancer Type: Breast Cancer; Colorectal Cancer; Blood Cancer; Neutropenia Cancer; Non-Small Cell Lung Cancer; Others; 3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Companies
Biocoin; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG; Pfizer Inc.; Apotex Inc.; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; BIOCAD; Amgen; Hospira; F Hoffmann-La Roche; Baxter; Sanofi; Mylan; F Hoffmann-La Roche
Table of Contents
Table of Contents
1. Executive Summary
2. Oncology Biosimilars Market Characteristics
3. Oncology Biosimilars Market Size And Growth
3.1. Global Oncology Biosimilars Historic Market, 2015-2019, USD Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Oncology Biosimilars Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Oncology Biosimilars Market Segmentation
4.1. Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Monoclonal Antibody
Immunomodulators
Hematopoietic Agents
Granulocyte Colony-Stimulating Factor (G-CSF)
4.2. Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Breast Cancer
Colorectal Cancer
Blood Cancer
Neutropenia Cancer
Non-Small Cell Lung Cancer
Others
4.3. Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
5. Oncology Biosimilars Market Regional And Country Analysis
5.1. Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
5.2. Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
6. Asia-Pacific Oncology Biosimilars Market
6.1. Asia-Pacific Oncology Biosimilars Market Overview
6.2. Asia-Pacific Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
7. China Oncology Biosimilars Market
7.1. China Oncology Biosimilars Market Overview
7.2. China Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion
8. India Oncology Biosimilars Market
8.1. India Oncology Biosimilars Market Overview
8.2. India Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
9. Japan Oncology Biosimilars Market
9.1. Japan Oncology Biosimilars Market Overview
9.2. Japan Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
10. Australia Oncology Biosimilars Market
10.1. Australia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
11. Indonesia Oncology Biosimilars Market
11.1. Indonesia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
12. South Korea Oncology Biosimilars Market
12.1. South Korea Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
13. Western Europe Oncology Biosimilars Market
13.1. Western Europe Oncology Biosimilars Market Overview
13.2. Western Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
14. UK Oncology Biosimilars Market
14.1. UK Oncology Biosimilars Market Overview
14.2. UK Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
15. Germany Oncology Biosimilars Market
15.1. Germany Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
16. France Oncology Biosimilars Market
16.3. France Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
17. Eastern Europe Oncology Biosimilars Market
17.1. Eastern Europe Oncology Biosimilars Market Overview
17.2. Eastern Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
18. Russia Oncology Biosimilars Market
18.1. Russia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
19. North America Oncology Biosimilars Market
19.1. North America Oncology Biosimilars Market Overview
19.2. North America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
20. USA Oncology Biosimilars Market
20.1. USA Oncology Biosimilars Market Overview
20.2. USA Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
21. South America Oncology Biosimilars Market
21.1. South America Oncology Biosimilars Market Overview
21.2. South America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
22. Brazil Oncology Biosimilars Market
22.1. Brazil Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
23. Middle East Oncology Biosimilars Market
23.1. Middle East Oncology Biosimilars Market Overview
23.2. Middle East Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
24. Africa Oncology Biosimilars Market
24.1. Africa Oncology Biosimilars Market Overview
24.2. Africa Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
25. Oncology Biosimilars Market Competitive Landscape And Company Profiles
25.1. Oncology Biosimilars Market Competitive Landscape
25.2. Oncology Biosimilars Market Company Profiles
25.2.1. Biocoin
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Celltrion Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Dr. Reddy's Laboratories Ltd.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Intas Pharmaceuticals Ltd.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. STADA Arzneimittel AG
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Oncology Biosimilars Market
27. Oncology Biosimilars Market Trends And Strategies
28. Oncology Biosimilars Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. The Business Research Company
29.5. Copyright And Disclaimer
List of Figure
Figure 1: Global Historic Market Growth, 2015-2019, USD Billion
Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 3: Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 4: Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 5: Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 6: Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 7: Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 8: Asia-Pacific, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 9: China, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 10: India, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 11: Japan, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 12: Australia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 13: Indonesia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 14: South Korea, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 15: Western Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 16: UK, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 17: Germany, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 18: France, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 19: Eastern Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 20: Russia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 21: North America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 22: USA, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 23: South America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 24: Brazil, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 25: Middle East, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 26: Africa, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Figure 27: Biocoin Financial Performance
Figure 28: Celltrion Inc. Financial Performance
Figure 29: Dr. Reddy's Laboratories Ltd. Financial Performance
Figure 30: Intas Pharmaceuticals Ltd. Financial Performance
Figure 31: STADA Arzneimittel AG Financial Performance
List of Table
Table 1: Global Historic Market Growth, 2015-2019, USD Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 3: Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 4: Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 5: Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 6: Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 7: Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 8: Asia-Pacific, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 9: China, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 10: India, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 11: Japan, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 12: Australia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 13: Indonesia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 14: South Korea, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 15: Western Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 16: UK, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 17: Germany, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 18: France, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 19: Eastern Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 20: Russia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 21: North America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 22: USA, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 23: South America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 24: Brazil, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 25: Middle East, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 26: Africa, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion
Table 27: Biocoin Financial Performance
Table 28: Celltrion Inc. Financial Performance
Table 29: Dr. Reddy's Laboratories Ltd. Financial Performance
Table 30: Intas Pharmaceuticals Ltd. Financial Performance
Table 31: STADA Arzneimittel AG Financial Performance
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.